Waters Corporation (WAT) recently completed the strategic merger with
BD's Biosciences & Diagnostic Solutions Businesses. However, the corporation's stock suffered a significant hit, dropping by over
10% on the day the deal closed as the newly-acquired BD business underperformed. Despite this setback, a
turnaround is projected following a 19.0% fall over four weeks. This projection comes even with shareholder approval of the combination with BD's Biosciences & Diagnostic Solutions and Q4 CY2025 results meeting expectations.
Madison Asset Management LLC and
GUARDCAP ASSET MANAGEMENT Ltd have decreased holdings in Waters Corporation, while
Nuance Investments LLC increased theirs. Waters' Q4 results surpassed estimates, displaying revenue growth. However, the company has lowered its stock price targets. Looking forward to 2026,
Guggenheim reiterated its 'Buy' rating on Waters Corporation with a bull-case theory that offsets the margin pressures from the acquisition.
Waters Corp WAT News Analytics from Thu, 10 Jul 2025 07:00:00 GMT to Fri, 13 Feb 2026 18:11:00 GMT -
Rating -4
- Innovation 0
- Information 5
- Rumor -2
